{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:45:14Z","timestamp":1785840314815,"version":"3.56.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.endonu.2012.06.006","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T06:01:06Z","timestamp":1346133666000},"page":"523-530","source":"Crossref","is-referenced-by-count":16,"title":["Glucagon receptor is required for long-term survival: A natural history study of the Mahvash disease in a murine model"],"prefix":"10.1016","volume":"59","author":[{"given":"Run","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Guang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mirocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.endonu.2012.06.006_bib0005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/MPA.0b013e31815ceb23","article-title":"Nesidioblastosis and hyperplasia of alpha cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas","volume":"36","author":"Yu","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.endonu.2012.06.006_bib0010","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/MPA.0b013e3181b2bb03","article-title":"Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor","volume":"38","author":"Zhou","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.endonu.2012.06.006_bib0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3748\/wjg.v17.i2.137","article-title":"Pathologic pancreatic endocrine cell hyperplasia","volume":"17","author":"Ouyang","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.endonu.2012.06.006_bib0020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.endonu.2011.04.002","article-title":"A natural inactivating mutant of human glucagon receptor exhibits multiple abnormalities in processing and signaling","volume":"58","author":"Yu","year":"2011","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.endonu.2012.06.006_bib0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1210\/jc.2008-1300","article-title":"Glucagon cell adenomatosis: a newly recognized disease of the endocrine pancreas","volume":"94","author":"Henopp","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2012.06.006_bib0030","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaad.2010.04.010","article-title":"Glucagon cell adenomatosis: a new entity associated with necrolytic migratory erythema and glucagonoma syndrome","volume":"65","author":"Otto","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.endonu.2012.06.006_bib0035","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/01.pas.0000194044.01104.25","article-title":"Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome","volume":"30","author":"Anlauf","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.endonu.2012.06.006_bib0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MPA.0b013e31815f394a","article-title":"Endocrine pancreatic tumors in von Hippel\u2013Lindau disease: clinical, histological and genetic features","volume":"37","author":"Corcos","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.endonu.2012.06.006_bib0045","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1006\/bbrc.2001.6265","article-title":"Glycemic control in mice with targeted disruption of the glucagon receptor gene","volume":"290","author":"Parker","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.endonu.2012.06.006_bib0050","doi-asserted-by":"crossref","first-page":"e23397","DOI":"10.1371\/journal.pone.0023397","article-title":"Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.endonu.2012.06.006_bib0055","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00125-006-0481-3","article-title":"Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia","volume":"50","author":"Conarello","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.endonu.2012.06.006_bib0060","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1210\/en.2005-1410","article-title":"Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation","volume":"147","author":"Vuguin","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.endonu.2012.06.006_bib0065","doi-asserted-by":"crossref","first-page":"E522","DOI":"10.1152\/ajpendo.00420.2011","article-title":"Hypoglycemia, hyperglucagonemia, and fetoplacental defects in glucagon receptor knockout mice: a role for glucagon action in pregnancy maintenance","volume":"302","author":"Ouhilal","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.endonu.2012.06.006_bib0070","doi-asserted-by":"crossref","first-page":"19541","DOI":"10.1073\/pnas.0604478104","article-title":"Hypoglycemia leads to age-related loss of vision","volume":"103","author":"Umino","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.endonu.2012.06.006_bib0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cmet.2008.09.008","article-title":"The glucagon receptor is required for the adaptive metabolic response to fasting","volume":"8","author":"Longuet","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.endonu.2012.06.006_bib0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1471-2164-12-281","article-title":"Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes","volume":"12","author":"Yang","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.endonu.2012.06.006_bib0085","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.2337\/db11-0455","article-title":"Hepatic glucagon action is essential for exercise-induced reversal of mouse fatty liver","volume":"60","author":"Berglund","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.endonu.2012.06.006_bib0090","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2559.2010.03490.x","article-title":"Endocrine tumours of the pancreas","volume":"56","author":"Verbeke","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.endonu.2012.06.006_bib0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00423-011-0739-1","article-title":"The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors","volume":"396","author":"Schimmack","year":"2011","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.endonu.2012.06.006_bib0100","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1053\/j.gastro.2010.01.046","article-title":"Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development","volume":"138","author":"Lu","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.endonu.2012.06.006_bib0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI60016","article-title":"Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover","volume":"122","author":"Unger","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.endonu.2012.06.006_bib0110","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1463-1326.2011.01427.x","article-title":"Glucagon antagonism as a potential therapeutic target in type 2 diabetes","volume":"13","author":"Bagger","year":"2011","journal-title":"Diabetes Obes Metab"}],"container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092212002252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092212002252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T06:55:54Z","timestamp":1542783354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1575092212002252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1575092212002252"],"URL":"https:\/\/doi.org\/10.1016\/j.endonu.2012.06.006","relation":{},"ISSN":["1575-0922"],"issn-type":[{"value":"1575-0922","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}